CDC Warns of Surge in Atrial Fibrillation Cases by 2030
The Centers for Disease Control and Prevention (CDC) projects a significant rise in atrial fibrillation (AFib) cases in the US. By 2030, nearly 12 million Americans are expected to have AFib, up from the current estimate of around 9 million by the American Heart Association. This common heart arrhythmia disrupts blood flow, increasing stroke and heart failure risks.
Atrial fibrillation occurs when the heart's upper chambers beat irregularly, leading to a faster or slower heart rate. A normal heart rate for adults over 10 years old ranges between 60 to 100 beats per minute. AFib symptoms can include heart palpitations, chest pain, fatigue, shortness of breath, and weakness. However, some people may not experience any symptoms at all.
AFib can be temporary, recurrent, or permanent. Medications play a crucial role in managing it. Beta-blockers, calcium channel blockers, class III antiarrhythmics, and cardiac glycosides are preferred for heart rate control, aiming to keep the resting heart rate below 110 beats per minute. These drugs effectively control ventricular rate and help prevent tachycardia-related issues. In cases with left ventricular systolic dysfunction, catheter ablation may provide superior rhythm control.
Atrial fibrillation is a growing health concern in the US, with projections showing a significant increase in cases by 2030. Proper medical care, including medication and regular checkups, can help manage AFib, reducing the risk of serious complications such as stroke and heart failure. If you experience any AFib symptoms, consult your doctor promptly.
Read also:
- Trump's SNAP reductions and New York City Council's grocery delivery legislation: Problems for city residents highlighted
- Reducing dental expenses for elderlies in Sweden: Over 50% cut in charges for pensioners by the government
- Forty-year-old diet: A list of meal choices to savor
- Exiled Life's Conundrum: A Blend of Liberation, Disillusionment, and Distress
